The estimated Net Worth of Meghan Scanlon is at least $2.08 Million dollars as of 1 May 2022. Ms. Scanlon owns over 2,062 units of Boston Scientific stock worth over $2,079,057 and over the last 5 years she sold BSX stock worth over $0. In addition, she makes $0 as Senior Vice President and President and Urology and Pelvic Health at Boston Scientific.
Meghan has made over 17 trades of the Boston Scientific stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 2,062 units of BSX stock worth $171,022 on 1 May 2022.
The largest trade she's ever made was exercising 16,450 units of Boston Scientific stock on 24 June 2021 worth over $283,927. On average, Meghan trades about 2,311 units every 35 days since 2020. As of 1 May 2022 she still owns at least 25,067 units of Boston Scientific stock.
You can see the complete history of Ms. Scanlon stock trades at the bottom of the page.
Meghan Scanlon serves as Senior Vice President and President, Urology and Pelvic Health of the Company. Since joining Boston Scientific in 2014 as vice president, global marketing for Endoscopy, she has progressed through roles of increasing responsibility in Urology and Pelvic Health and Endoscopy, and played a significant role in driving and shaping the global commercial organization structures and portfolio innovation strategies for both businesses. Prior to joining Boston Scientific, Ms. Scanlon spent nearly 15 years in leadership roles within the Johnson & Johnson medical device business and started her early career as a design engineer at Gillette. She holds a B.S. in Mechanical Engineering from Tufts University and both her M.B.A. and M.S.M.E. from Massachusetts Institute of Technology.
Meghan Scanlon is 47, she's been the Senior Vice President and President and Urology and Pelvic Health of Boston Scientific since 2020. There are 28 older and no younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Meghan's mailing address filed with the SEC is C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD, CO, 80112.
Over the last 20 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele, and Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: